HOPA 2020: Mogamulizumab Is Generally Well Tolerated in Previously Treated Mycosis Fungoides or Sézary Syndrome
Longer follow-up and treatment exposure did not identify any new safety signals.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.